Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

We Work for Health New Jersey (WWFH-NJ)

Mayors Committee on Life Sciences Patient Courage Award Presented to Ralph Wehmann in Alpine

(L. to r.) Ralph Wehmann, Alpine Mayor Paul Tomasko and Dean Paranicas

Alpine, NJ, November 28, 2017 —The Mayors Committee on Life Sciences on November 20 presented its Patient Courage Award to Alpine resident Ralph Wehmann, in recognition of his strength in the face of adversity and commitment to helping others.

The honor was presented by Dean J. Paranicas, who serves as President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ) and a Co-Chair of We Work for Health New Jersey, during the Alpine Mayor and Council meeting.

Mr. Wehmann’s battle with myelodysplastic syndrome (MDS) began in 2012. It was not his first brush with a life-threatening illness, so it came as no surprise to those that know him that he fought back with the same determination and positive spirit he had demonstrated previously. Continue reading

Mayors Committee on Life Sciences Presents Patient Courage Award to David Dubin in Haworth

(L. to r.) Mayor John Smart, David Dubin and Dean Paranicas

Haworth, NJ, October 27, 2017 — During the Haworth Borough Council meeting on Tuesday night, the Mayors Committee on Life Sciences presented its Patient Courage Award to Haworth resident David Dubin, in recognition of his strength in the face of adversity and commitment to helping others.

The honor was presented by HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas, who serves as a Co-Chair of We Work for Health New Jersey.

Mr. Dubin has Lynch syndrome and is a three-time cancer survivor.  Lynch syndrome is caused by a genetic mutation that increases the risk for certain types of cancers.  He was first diagnosed with colon cancer in 1997 but did not undergo genetic testing until the cancer returned in 2007. Continue reading

PhRMA Releases ‘Research in Your Backyard’ for New Jersey; PhRMA, HINJ and WWFH-NJ Host Discussion Focused on Biopharma Research in Garden State

New Brunswick, NJ, September 16, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) on June 28 released a new report entitled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 patients participated in clinical trials around the state in 2013, generating an estimated economic impact of $617 million.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey on June 28.

In addition to a presentation of the new PhRMA report, the event featured a panel discussion of industry experts that was moderated by HINJ President and Chief Executive Officer Dean J. Paranicas.  The panelists were: Continue reading

PhRMA’s ‘Research in Your Backyard’ for New Jersey Explores Clinical Trials’ State Impact

New Brunswick, NJ, September 15, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) on June 28 released a new report entitled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 patients participated in clinical trials around the state in 2013, generating an economic impact of $617 million.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey. Continue reading

PhRMA Releases ‘Research in Your Backyard’ for New Jersey; PhRMA, HINJ and WWFH-NJ Host Discussion Focused on Biopharma Research in Garden State

New Brunswick, NJ, June 28, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) today released a new report titled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 New Jersey patients participate in clinical trials around the state, generating $617 million in economic growth.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey.

In addition to a presentation of the new PhRMA report, the event featured a panel discussion of industry experts that was moderated by HINJ President and Chief Executive Officer Dean J. Paranicas: Continue reading

HINJ Partners with PILMA and WWFH-NJ to Host Life Sciences-Organized Labor Training Facility Tour for Rep. MacArthur

(L. to r.) HINJ CEO Dean Paranicas, IUOE Local 85 Business Manager Greg Lavelee, Sen. Steve Sweeney and Rep. Tom MacArthur

New Brunswick, NJ, June 27, 2017 — The HealthCare Institute of New Jersey (HINJ), along with the Pharmaceutical Industry-Labor Management Association (PILMA) and We Work For Health – New Jersey (WWFH-NJ), hosted an organized labor training facility tour for Congressman Tom MacArthur (R-NJ-3rd) on May 12.

New Jersey Senate President Stephen M. Sweeney (D-Gloucester) also attended the event, which was held at the International Union of Operating Engineers (IUOE) Local 825 Training Grounds in Dayton, NJ.

To view a video from the tour — including brief comments from Congressman MacArthur and Senate President Sweeney — please click here. Continue reading

Tomorrow! HINJ, Rx4NJ and WWFH-NJ to Host ‘The Value of Medical Innovation’ Health Policy Forum December 15

Healthcare PolicyNew Brunswick, NJ, December 13, 2015 ― Please join the HealthCare Institute of New Jersey (HINJ), the Rx4NJ Partnership and We Work for Health New Jersey for a health policy forum that will focus on “The Value of Medical Innovation: Saving Lives, Saving Money.”

The forum will be held on Tuesday, December 15 from 8:30 to 11:00 a.m. at Forsgate Country Club at 375 Forsgate Drive, Monroe Township, NJ.

Topics to be covered include:

  • How medical innovation is bending the cost curve
  • Value to patients
  • Economic impact
  • Challenges and changes in the health-care marketplace

Admission is free, but seating is limited.  To register, click here. Continue reading